Inhibitory activity of vitamin E and α-naphthoflavone on β-carotene-enhanced transformation of BALB/c 3T3 cells by benzo(a)pyrene and cigarette-smoke condensate

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 465, Issue 1-2, 2000, Pages 151-158

  Perocco, P ^a   Mazzullo, M ^a   Broccoli, M ^a   Rocchi, P ^a   Ferreri, A M ^a   Paolini, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Naphthoflavone; Carotene; BALB c 3T3 cells; Cell transformation; Environmental risk; Vitamin E

Indexed keywords

ALPHA NAPHTHOFLAVONE; ALPHA TOCOPHEROL; BENZO[A]PYRENE; BETA CAROTENE; CIGARETTE SMOKE CONDENSATE;

ANIMAL CELL; ARTICLE; CARCINOGENIC ACTIVITY; CELL STRAIN 3T3; CONTROLLED STUDY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; BENZO(A)PYRENE; BENZOFLAVONES; BETA CAROTENE; BIOTRANSFORMATION; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; COCARCINOGENESIS; DRUG INTERACTIONS; HUMANS; MICE; PLANTS, TOXIC; SMOKE; TOBACCO; VITAMIN E;

EID: 0034673203     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00223-5     Document Type: Article

References (28)

1. J.M. Graziano, C.H. Hennekens, The role of β-carotene in the prevention of cardiovascular disease, Ann. New York Acad. Sci. 691 (1993) 148-155.
2. S.T. Mayne, β-Carotene, carotenoids, and disease prevention in humans, FASEB J. 10 (1996) 690-701.
3. W.J. Blot, J.Y. Li, P.R. Taylor, W. Guo, S. Dawsey, G.Q. Wang, C.S. Yang, S.F. Zheng, M. Gail, G.Y. Li, Y. Yu, B.Q. Lin, J. Tangrea, Y.H. Sun, F. Liu, J.F. Fraumeni Jr., Y.H. Zang, B. Li, Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population, J. Natl. Cancer Inst. 85 (1993) 1483-1491.
4. D.P. Jones, V.E. Kagan, S.D. Aust, D.J. Reed, S.T. Omaye, Impact of nutrient on cellular lipid peroxidation and antioxidant defense system, Fundam. Appl. Toxicol. 26 (1995) 1-7.
5. Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group (ATBC), The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers, N. Engl. J. Med. 330 (1994) 1029-1035.
6. G.S. Omenn, G.E. Goodman, M.D. Thornquist, J. Balmes, M.R. Cullen, A. Glass, J.P. Keogh, F.L. Meyskens, B. Valanis, J.H. Williams, S. Barnhart, M.G. Cherniack, C.A. Brodkin, S. Hammar, Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial, J. Natl. Cancer Inst. 88 (1996) 1550-1558.
7. S.T. Omaye, N.I. Krinsky, V.E. Kagan, S.T. Mayne, D.C. Liebler, W.R. Bidlack, β-Carotene: friend or foe?, Fundam. Appl. Toxicol. 40 (1997) 163-174.
8. E. Buiatti, An overview of recent results of chemoprevention trials, in: C. Maltoni, M. Soffritti, W. Davis (Eds.), The Scientific Bases of Cancer Chemoprevention, Elsevier, Amsterdam, 1996, pp. 257-266.
9. M. Paolini, G. Cantelli-Forti, P. Perocco, G.F. Pedulli, S.Z. Abdel-Rahman, M.S. Legator, Co-carcinogenic effect of β-carotene, Nature 398 (1999) 760-761.
10. P. Perocco, M. Paolini, M. Mazzullo, G.L. Biagi, G. Cantelli-Forti, β-Carotene as enhancer of cell transforming activity of powerful carcinogens and cigarette-smoke condensate on BALB/c 3T3 cells in vitro, Mutat. Res. 440 (1999) 83-90.
11. L. Diamond, H.V. Gelboin, α-Naphthoflavone: an inhibitor of hydrocarbon cytotoxicity and microsomal hydroxylase, Science 166 (1969) 1023-1025.
12. IARC/NCI/EPA Working Group, Cellular and molecular mechanisms of cell transformation and standardization of transformation assays of established cell lines for the prediction of carcinogenic chemicals: overview and recommended protocols, Cancer Res. 45 (1985) 2395-2399.
13. L.M. Schechtman, BALB/c 3T3 cell transformation: protocols, problems and improvements, in: T. Kakunaga, H. Yamasaki (Eds.), Transformation Assay of Established Cell Lines: Mechanisms and Application, IARC Scientific Publications, vol. 67, International Agency for Research on Cancer, Lyon, 1985, pp. 165-184.
14. R.A. Lubet, R.E. Kouri, R.A. Curren, D.L. Putman, L.M. Schechtman, Induction of mutagenesis and transformation in BALB/c 3T3 clone A31-1 cells by diverse chemical carcinogens, Environ. Mol. Mutagen. 16 (1990) 13-20.
15. H.V. Gelboin, Benzo(a)pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes, Physiol. Rev. 60 (1980) 1107-1166.
16. C. Colin, J.F. Narbonne, M.L. Migaud, P. Grolier, P. Cassand, M.A. Pellissier, Lipid peroxidation and benzo[a]pyrene activation to mutagenic metabolites: in vivo influence of vitamins A, E and C and glutathione in both dietary vitamin A sufficiency and deficiency, Mutat. Res. 246 (1991) 159-168.
17. W.A. Pryor, Free radical biology: xenobiotics, cancer, and aging, in: B. Lubin, L.J. Machlin (Eds.), Vitamin E: Biochemical, Hematological, and Clinical Aspects, N.Y. Acad. Sci., New York, 1982, pp. 1-22.
18. J.D. Gower, E.D. Wills, The generation of oxidation products of benzo[a]pyrene by lipid peroxidation: a study using γ-irradiation, Carcinogenesis 5 (1984) 1183-1189.
19. M.A. Trush, J.L. Seed, T.W. Kensler, Oxidant-dependent metabolic activation of polycyclic aromatic hydrocarbons by phorbol ester-stimulated human polymorphonuclear leukocytes: possible link between inflammation and cancer, Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 5194-5198.
20. T.A. Dix, R. Fontana, A. Panthani, L.J. Marnett, Hematincatalyzed epoxidation of 7,8-dihydroxy-7,8-dihydrobenzo-[a]pyrene by polyunsaturated fatty acid hydroperoxides, J. Biol. Chem. 10 (1985) 5358-5365.
21. R.J. Lorentzen, P.O. Ts'o, Benzo[a]pyrenedione/ benzo[a]pyrenediol oxidation-reduction couples and the generation of reactive reduced molecular oxygen, Biochemistry 16 (1977) 1467-1473.
22. G.S. Ladies, T.T. Kawabata, A.E. Munson, K.L. White Jr., Generation of 7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydro-benzo[a]pyrene by murine splenic macrophages, Toxicol. Appl. Pharmacol. 115 (1992) 72-79.
23. P. Joseph, A.K. Jaiswal, NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones, Br. J. Cancer 77 (1998) 709-719.
24. M. Paolini, L. Pozzetti, G.F. Pedulli, M. Cipollone, R. Mesirca, G. Cantelli-Forti, Paramagnetic resonance in detecting carcinogenic risk from cytochrome P450 overexpression, J. Invest. Med. 44 (1996) 470-473.
25. S. Puntarulo, A.I. Cederbaum, Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes, Free Radical Biol. Med. 24 (1998) 1324-1330.
26. M.G. Salgo, R. Cueto, G.W. Winston, W.A. Pryor, Beta carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA, Free Radical Biol. Med. 26 (1999) 162-173.
27. D. Albanes, O.P. Neinonen, P.R. Taylor, J. Virtamo, B.K. Edwards, M. Rautalahti, A.M. Hartman, J. Palmgren, L.S. Freedman, J. Haapakoski, M.J. Barrett, P. Pietinen, N. Malila, E. Tala, K. Liippo, E.-R. Salomaa, J.A. Tangrea, L. Teppo, F.B. Askin, E. Taskinen, Y. Erozan, P. Greenwald, J.K. Huttunen, α-Tocopherol and β-carotene supplements and lung cancer incidence in the α-tocopherol, β-carotene cancer prevention study: effects of base-line characteristics and study compliance, J. Natl. Cancer Inst. 88 (1996) 1560-1570.
28. M. Paolini, R. Mesirca, L. Pozzetti, N. Gialluca, C. Bauer, G.L. Biagi, G. Cantelli-Forti, Cancer chemoprevention: some complications and limitations, Cancer Detect. Prev. 22 (1998) 68-74.